계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Paragon Genomics, Inc.
company
About
provide high-quality target enrichment solutions to the genomics community to advance precision medicine and research
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $8M
- Industries
- Biotechnology,Emergency Medicine,Health Care,Information Technology
- Founded date
- Jan 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
At Paragon Genomics, we develop and commercialize rapid, easy-to-use, ultra-high multiplex PCR-based target enrichment solutions for Next-Generation Sequencing (NGS). Our proprietary CleanPlex® background-removing technology enables NGS customers to develop targeted sequencing assays that are accurate, sensitive, and simple, yet cost effective. Our technology is applicable to many fast-growing NGS segments such as cancer research, liquid biopsy, biomarker discovery, genomics-guided breeding, companion diagnostics, and immunotherapy monitoring.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$8M
Paragon Genomics, Inc. has raised a total of
$8M
in funding over 2 rounds. Their latest funding was raised on
Sep 12, 2017 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 12, 2017 | Series A | $8M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Paragon Genomics, Inc. is funded by 1 investors.
Cloudstone Venture
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
